WEDNESDAY, May 25, 2022 (HealthDay News) — Doctors need to be aware that prostate cancer raises a man’s risk of serious and potentially deadly blood clots by about 50%, researchers say. All cancer patients are at increased risk for venous thromboembolism (VTE), a dangerous but treatable blood clot in theContinue Reading
MONDAY, May 23, 2022 (HealthDay News) — Americans with sickle cell disease who have private insurance face average out-of-pocket costs of $1,300 a year and a lifetime total of $44,000, new research reveals. That means that their out-of-pocket expenses are nearly four times higher compared to people without the inheritedContinue Reading
THURSDAY, May 5, 2022 (HealthDay News) — Citing the accumulated data on a raised risk for a type of dangerous blood clot, the U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine. With safer two-dose vaccines such as Pfizer andContinue Reading
WEDNESDAY, April 27, 2022 (HealthDay News) — People with sickle cell disease who take corticosteroids to treat asthma or inflammation may suffer severe pain and even need to be hospitalized, researchers report. This reaction to corticosteroids can be particularly severe among older people, women and patients not taking the drugContinue Reading
TUESDAY, April 26, 2022 (HealthDay News) — Women are less likely than men to head back to their jobs after recovering from a severe stroke, but researchers say the reasons for that difference are unclear. “Returning to work after a severe stroke is a sign of successful rehabilitation,” said leadContinue Reading
FRIDAY, April 15, 2022 (HealthDay News) — Cancer patients’ blood type may play a role in their risk for dangerous blood clots, researchers say. Cancer and its treatments increase the risk for venous thromboembolism (VTE). That includes deep-vein thrombosis (DVT, a blood clot that typically forms in the deep veinsContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — COVID-19 increases people’s risk of dangerous blood clots and bleeding for months after infection, researchers say. The new findings suggest that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding. “Our findings arguably support [treatment] to avoid thromboticContinue Reading
WEDNESDAY, March 30, 2022 (HealthDay News) — The chances of a severe allergic reaction being triggered by intravenous (IV) iron formulations for anemia are higher with some than others, but all pose a low risk, a new study says. Researchers compared five IV formulations commonly used to treat iron deficienciesContinue Reading
FRIDAY, Feb. 18, 2022 (HealthDay News) — “Rogue antibodies” that seem to trigger severe blood clotting and illness in COVID-19 patients have been identified by scientists. Their analysis of blood samples from 244 patients hospitalized for COVID-19 revealed circulating antiphospholipid antibodies, which are autoantibodies that target a person’s own organsContinue Reading
THURSDAY, Feb. 3, 2022 (HealthDay News) — A newer type of “clot-busting” medication might be safer than the one long used for treating strokes, a preliminary study hints. Researchers found that among nearly 7,900 stroke sufferers, those treated with the drug — called tenecteplase — were less likely to sufferContinue Reading